Effects of Phospholipase A(2) and Its Products on Structural Stability of Human LDL: Relevance to Formation of LDL-derived Lipid Droplets

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2011 Jan 12

PMID 21220788

Citations 17

Authors

Shobini Jayaraman

Donald L Gantz

Olga Gursky

Affiliations

Soon will be listed here.

Abstract

Hydrolysis and oxidation of LDL stimulate LDL entrapment in the arterial wall and promote inflammation and atherosclerosis via various mechanisms including lipoprotein fusion and lipid droplet formation. To determine the effects of FFA on these transitions, we hydrolyzed LDL by phospholipase A(2) (PLA(2)), removed FFA by albumin, and analyzed structural stability of the modified lipoproteins. Earlier, we showed that heating induces LDL remodeling, rupture, and coalescence into lipid droplets resembling those found in atherosclerotic lesions. Here, we report how FFA affect these transitions. Circular dichroism showed that mild LDL lipolysis induces partial β-sheet unfolding in apolipoprotein B. Electron microscopy, turbidity, and differential scanning calorimetry showed that mild lipolysis promotes LDL coalescence into lipid droplets. FFA removal by albumin restores LDL stability but not the protein conformation. Consequently, FFA enhance LDL coalescence into lipid droplets. Similar effects of FFA were observed in minimally oxidized LDL, in LDL enriched with exogenous FFA, and in HDL and VLDL. Our results imply that FFA promote lipoprotein coalescence into lipid droplets and explain why LDL oxidation enhances such coalescence in vivo but hampers it in vitro. Such lipid droplet formation potentially contributes to the pro-atherogenic effects of FFA.

Citing Articles

ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients.

La Chica Lhoest M, Martinez A, Garcia E, Dandurand J, Polishchuk A, Benitez-Amaro A J Lipid Res. 2024; 66(1):100703.

PMID: 39557294 PMC: 11731490. DOI: 10.1016/j.jlr.2024.100703.

Nonalcoholic Fatty Liver Disease Risk and Proprotein Convertase Subtilisin Kexin 9 in Familial Hypercholesterolemia Under Statin Treatment.

Hamasaki M, Sakane N, Kotani K Nutrients. 2024; 16(21).

PMID: 39519519 PMC: 11547339. DOI: 10.3390/nu16213686.

LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery.

Jayaraman S, Perez A, Minambres I, Sanchez-Quesada J, Gursky O J Lipid Res. 2023; 64(11):100451.

PMID: 37777014 PMC: 10665669. DOI: 10.1016/j.jlr.2023.100451.

Can Electronegative LDL Act as a Multienzymatic Complex?.

Benitez S, Puig N, Rives J, Sole A, Sanchez-Quesada J Int J Mol Sci. 2023; 24(8).

PMID: 37108253 PMC: 10138509. DOI: 10.3390/ijms24087074.

Aggregation Susceptibility of Low-Density Lipoproteins-A Novel Modifiable Biomarker of Cardiovascular Risk.

Oorni K, Kovanen P J Clin Med. 2021; 10(8).

PMID: 33921661 PMC: 8074066. DOI: 10.3390/jcm10081769.

References

Wilensky R, Macphee C . Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr Opin Lipidol. 2009; 20(5):415-20. DOI: 10.1097/MOL.0b013e3283307c16. View

Williams K, Tabas I . The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995; 15(5):551-61. PMC: 2924812. DOI: 10.1161/01.atv.15.5.551. View

Smith E . Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina. Eur Heart J. 1990; 11 Suppl E:72-81. DOI: 10.1093/eurheartj/11.suppl_e.72. View

White H . Editorial: why inhibition of lipoprotein-associated phospholipase A2 has the potential to improve patient outcomes. Curr Opin Cardiol. 2010; 25(4):299-301. DOI: 10.1097/HCO.0b013e32833aaa94. View

Jonsson-Rylander A, Lundin S, Rosengren B, Pettersson C, Hurt-Camejo E . Role of secretory phospholipases in atherogenesis. Curr Atheroscler Rep. 2008; 10(3):252-9. DOI: 10.1007/s11883-008-0039-6. View

Oorni K, Pentikainen M, Ala-Korpela M, Kovanen P . Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J Lipid Res. 2000; 41(11):1703-14. View

Liu H, Scraba D, Ryan R . Prevention of phospholipase-C induced aggregation of low density lipoprotein by amphipathic apolipoproteins. FEBS Lett. 1993; 316(1):27-33. DOI: 10.1016/0014-5793(93)81730-n. View

Plihtari R, Hurt-Camejo E, Oorni K, Kovanen P . Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase. J Lipid Res. 2010; 51(7):1801-9. PMC: 2882729. DOI: 10.1194/jlr.M003103. View

Wang L, Walsh M, Small D . Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces. Proc Natl Acad Sci U S A. 2006; 103(18):6871-6. PMC: 1458986. DOI: 10.1073/pnas.0602213103. View

10.

Zhang W, Schwartz E, Wang Y, Attrep J, Li Z, Reaven P . Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells. Arterioscler Thromb Vasc Biol. 2005; 26(3):514-9. DOI: 10.1161/01.ATV.0000200226.53994.09. View

11.

Gursky O . Apolipoprotein structure and dynamics. Curr Opin Lipidol. 2005; 16(3):287-94. DOI: 10.1097/01.mol.0000169348.61191.ac. View

12.

Morrison W, Smith L . PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL. J Lipid Res. 1964; 5:600-8. View

13.

Oorni K, Kovanen P . Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis. Curr Opin Lipidol. 2009; 20(5):421-7. DOI: 10.1097/MOL.0b013e32832fa14d. View

14.

Jayaraman S, Gantz D, Gursky O . Structural basis for thermal stability of human low-density lipoprotein. Biochemistry. 2005; 44(10):3965-71. DOI: 10.1021/bi047493v. View

15.

Deckelbaum R, Ramakrishnan R, Eisenberg S, Olivecrona T . Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry. 1992; 31(36):8544-51. DOI: 10.1021/bi00151a023. View

16.

Gaubatz J, Gillard B, Massey J, Hoogeveen R, Huang M, Lloyd E . Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2). J Lipid Res. 2006; 48(2):348-57. DOI: 10.1194/jlr.M600249-JLR200. View

17.

Bancells C, Villegas S, Blanco F, Benitez S, Gallego I, Beloki L . Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion. J Biol Chem. 2010; 285(42):32425-35. PMC: 2952244. DOI: 10.1074/jbc.M110.139691. View

18.

Lahdesmaki K, Plihtari R, Soininen P, Hurt-Camejo E, Ala-Korpela M, Oorni K . Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH. Atherosclerosis. 2009; 207(2):352-9. DOI: 10.1016/j.atherosclerosis.2009.04.031. View

19.

Rosenson R, Gelb M . Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes. Curr Cardiol Rep. 2009; 11(6):445-51. DOI: 10.1007/s11886-009-0064-2. View

20.

Chisolm G, Steinberg D . The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000; 28(12):1815-26. DOI: 10.1016/s0891-5849(00)00344-0. View